Australian Women and Girls' Health Research Centre, School of Public Health, The University of Queensland, Brisbane, Queensland, Australia.
Australian Women and Girls' Health Research Centre, School of Public Health, The University of Queensland, Brisbane, Queensland, Australia.
Fertil Steril. 2024 Feb;121(2):314-322. doi: 10.1016/j.fertnstert.2023.11.008. Epub 2023 Dec 12.
To study the fertility treatment pathways used by women with and without polycystic ovary syndrome (PCOS) and which pathways were more likely to result in a birth.
This retrospective national community-based cohort study used longitudinal self-report survey data (collected 1996-2022; aged 18-49 years) from women born in 1973-1978 who are participants in the Australian Longitudinal Study on Women's Health. The study also used linked administrative data on fertility treatments (1996-2021).
Of the 8,463 eligible women, 1,109 accessed fertility treatment and were included.
Polycystic ovary syndrome diagnosis was self-reported.
use of ovulation induction (OI), intrauterine insemination, and/or in vitro fertilization (IVF) was established through linked administrative data. Births were self-reported.
One in 10 of the eligible participants had PCOS (783/7,987, 10%) and 1 in 4 of the women who used fertility treatment had PCOS (274/1,109, 25%). Women with PCOS were 3 years younger on average at first fertility treatment (M = 31.4 years, SD = 4.18) than women without PCOS (M = 34.2 years, SD = 4.56). Seven treatment pathways were identified and use differed by PCOS status. Women with PCOS were more likely to start with OI (71%; odds ratio [OR] 4.20, 95% confidence interval [CI]: 2.91, 6.07) than women without PCOS (36%). Of the women with PCOS who started with OI, 46% required additional types of treatment. More women without PCOS ended up in IVF (72% vs. 51%). Overall, 63% (701/1,109) had an attributed birth, and in adjusted regressions births did not vary by last type of treatment (IVF: 67%, reference; intrauterine insemination: 67%, OR 0.94 95% CI: 0.56, 1.58; OI: 61%, OR 0.71, 95% CI: 0.52, 0.98), or by PCOS status (OR 1.27, 95% CI: 0.91, 1.77). By age, 74% of women under 35 years (471/639) and 49% of women 35 years or older had a birth.
More women with PCOS used fertility treatment but births were equivalent to women without PCOS. Most women followed clinical recommendations. Births did not differ between pathways, so there was no disadvantage in starting with less invasive treatments (although there may be financial or emotional disadvantages).
研究患有和不患有多囊卵巢综合征(PCOS)的女性使用的生育治疗途径,以及哪些途径更有可能导致生育。
这是一项基于全国社区的回顾性队列研究,使用了澳大利亚妇女健康纵向研究中 1973 年至 1978 年出生的年龄在 18 至 49 岁的女性的纵向自我报告调查数据(1996 年至 2022 年收集)。该研究还使用了与生育治疗相关的链接行政数据(1996 年至 2021 年)。
在符合条件的 8463 名女性中,有 1109 名接受了生育治疗并被纳入研究。
多囊卵巢综合征的诊断是自我报告的。
通过链接的行政数据确定使用促排卵(OI)、宫腔内人工授精和/或体外受精(IVF)的情况。生育情况是自我报告的。
符合条件的参与者中,有 10%(783/7987)患有 PCOS,有 25%(274/1109)接受生育治疗的女性患有 PCOS。与无 PCOS 的女性相比(M = 34.2 岁,SD = 4.56),患有 PCOS 的女性首次接受生育治疗的年龄平均年轻 3 岁(M = 31.4 岁,SD = 4.18)。确定了 7 种治疗途径,且途径的使用因 PCOS 状态而异。与无 PCOS 的女性相比(36%),患有 PCOS 的女性更有可能首先接受 OI(71%;优势比 [OR] 4.20,95%置信区间 [CI]:2.91,6.07)。在首先接受 OI 的 PCOS 女性中,有 46%需要额外的治疗类型。更多无 PCOS 的女性最终接受了 IVF(72%比 51%)。总体而言,63%(701/1109)有归因于生育的情况,在调整后的回归分析中,最后一种治疗类型(IVF:67%,参考;宫腔内人工授精:67%,OR 0.94,95%CI:0.56,1.58;OI:61%,OR 0.71,95%CI:0.52,0.98)或 PCOS 状态(OR 1.27,95%CI:0.91,1.77)并不影响生育。按年龄划分,74%的 35 岁以下女性(471/639)和 49%的 35 岁及以上女性有生育。
患有 PCOS 的女性更有可能使用生育治疗,但生育结果与无 PCOS 的女性相当。大多数女性遵循临床推荐。不同途径之间的生育情况没有差异,因此从侵入性较小的治疗开始并没有劣势(尽管可能存在经济或情感方面的劣势)。